Background: Pancreaticoduodenectomy (PD), as a challenging surgical procedure, is associated with considerable morbidity and mortality rates. Currently, the impact of preoperative biliary drainage (PBD) on the surgical risk of PD remains controversial. Therefore, we conducted a retrospective cohort study to analyze factors influencing the surgical risk of PD and to evaluate the role of biliary drainage therein. Methods: A retrospective analysis was performed on the clinical data of 354 patients with periampullary malignancies who underwent PD at Beijing Friendship Hospital, Capital Medical University, between June 2017 and October 2022. Through comprehensive scoring based on surgical approach, operative time, and intraoperative blood loss, we derived surgical risk scores and stratified patients into high-risk and low-risk groups. Variables including patient history, preoperative procedures, and laboratory and imaging findings were included in least absolute shrinkage and selection operator (LASSO) regression to identify variables at the optimal lambda value. These variables were then incorporated into binary multivariate logistic regression to analyze factors influencing the surgical risk of PD. Furthermore, we analyzed influencing factors specifically in patients who underwent PBD to identify risk factors affecting surgical risk in this subgroup. Results: A total of 354 patients were included in this study, with 195 cases stratified into the low-risk group and 159 cases assigned to the high-risk group. Among all 354 enrolled patients, 184 did not undergo PBD, while 170 underwent PBD. Analysis revealed that the biliary drainage group had a higher surgical risk compared to the non-drainage group [odds ratio (OR): 1.615; 95% confidence interval (CI): 1.020–2.556, P=0.04]. Further analysis of the impact of different biliary drainage methods on surgical difficulty showed that, among patients who underwent PBD, retrograde drainage was a risk factor for surgical risk (OR: 2.032; 95% CI: 1.016–4.064, P=0.045). Conclusions: PBD was identified as an independent risk factor for elevated surgical risk in PD. Among patients undergoing biliary drainage, retrograde drainage, compared to antegrade drainage, is an independent risk factor for surgical risk.
Background Frizzled 7, a G protein-coupled receptor, can regulate cell proliferation, migration, and tumorigenesis. The effect of FZD7 on prognosis and the immune microenvironment in pan-cancer remains elusive. Hence, we plan to provide insight into FZD7's role in pan-cancer. Methods FZD7 expression was analyzed by integrating RNA sequencing data from TCGA and GEO databases. Furthermore, we elucidated the correlation between FZD7 and prognosis, mutation landscape, immune infiltration, and biological function by analyzing multiple databases in pan-cancer. A prognostic risk model was constructed based on the sequencing data of HCC in the TCGA database and its validity was verified in the GEO database. In addition, reverse transcription-polymerase chain reaction assays were performed to validate FZD7 expression in HCC tumor tissues. Results Compared with adjacent noncancerous tissues, FZD7 was upregulated in several tumor tissues, especially HCC, and its elevated expression account for tumor progression and poor prognosis. Significant associations were found between FZD7 expression and TMB or MSI in several tumors. Immune infiltration analysis revealed a close link between FZD7 expression and the presence of myeloid-derived suppressor cells, T cell regulatory, as well as the cancer-associated fibroblasts. However, it negatively correlated with CD4+ Th1 cell and CD4+ Th2 infiltration. FZD7-related functional genes were successfully incorporated into the construction and validation of an HCC prognostic risk model. Conclusion Our study indicated that FZD7 is involved in regulating the progression of several tumors and immune infiltration, while it can serve as an effective prognosis biomarker in pan-cancer, especially HCC. This could shed light on tumor therapy.
Background/Objectives: Hepatocellular carcinoma (HCC) remains a major malignancy with high incidence and mortality, in part due to its diverse etiology and intratumoral heterogeneity, which contributes to drug resistance and frequent recurrence. SALL1 (Spalt-Like Transcription Factor 1), a zinc-finger transcription factor, was reported to function as a tumor suppressor in several cancers, including breast cancer and glioma, and accumulating evidence support its involvement in tumor biology. In this study, the role of SALL1 in HCC was examined. Methods: Public RNA and protein databases derived from human HCC were interrogated. Western blotting quantification of clinical HCC for SALL1 levels was carried out. Cell culture and xenograft studies were performed using genetically modified HCC tumor cells. Results: As revealed by pubic RNA and protein database analysis and further western blotting quantification of clinical samples of HCC, SALL1 is decreased in human HCC. The effect of reduced SALL1 expression on the tumorigenic properties and transcriptional regulation in HCC was then examined. Knockdown of SALL1 in the HCC cell lines Huh7 and Hep3B, enhanced cell proliferation in vitro and accelerated tumor growth in a xenograft mouse model, suggesting that lower SALL1 expression increases cell proliferation and tumorigenesis in HCC. RNA-seq and ChIP analyses further identified three novel candidate target genes (SLC6A14, GABRG1, and AKR1B10), suggesting that SALL1 may exert a tumor-suppressive effect, at least in part, through negative regulation of these genes. Conclusions: These findings establish SALL1 as a possible tumor suppressor and provide new insights into the biological significance of SALL1 downregulation in HCC. SALL1 could be a candidate prognostic marker and a potential therapeutic target.
1 March 2026 in Translational Gastroenterology and Hepatology
Original Article Association of pre-drainage bilirubin levels and pathological features with survival in patients undergoing preoperative biliary drainage: a single-center retrospective study Yiyang Min, Huajun Lin, Chenglin Xin, Yuheng Hu, Wei Guo, Dong Wang, Zhongtao Zhang
1 May 2026 in Translational Gastroenterology and Hepatology
Circulating tumor cells (CTCs) are pivotal in determining postoperative prognosis in periampullary carcinoma. However, the influence of preoperative biliary drainage (PBD) on CTC levels after pancreaticoduodenectomy (PD) remains unclear. Therefore, we explored the correlation of PBD with post-PD CTC changes in patients with resectable periampullary carcinoma and obstructive jaundice. We conducted a retrospective analysis of 125 patients with periampullary malignancies who underwent PD at Beijing Friendship Hospital, Capital Medical University, between June 2017 and October 2024. Participants were stratified into PBD and non-PBD (control) groups. Propensity score matching (PSM) was employed to balance baseline characteristics, followed by binary multivariate logistic regression. Multiple linear regression was further utilized to identify factors influencing postoperative CTC levels. Serial CTC analysis demonstrated a significantly higher rate of postoperative CTC reduction in the PBD group compared to the control group (64.3% vs. 27.3%, P<0.001), along with a greater proportion of patients converting from CTC-positive to CTC-negative status (35.7% vs. 0%, P<0.001). Subgroup analysis revealed that antegrade drainage was superior to retrograde drainage in reducing postoperative bilirubin levels (P<0.05). Binary logistic regression confirmed PBD as an independent protective factor against postoperative CTC increase (P<0.01). PBD was significantly associated with postoperative positive-to-negative CTC conversion and lower postoperative CTC levels. These findings support the role of PBD as an independent protective factor against CTC elevation following surgery.